| UniProt ID | OTU7B_HUMAN | |
|---|---|---|
| UniProt AC | Q6GQQ9 | |
| Protein Name | OTU domain-containing protein 7B | |
| Gene Name | OTUD7B | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 843 | |
| Subcellular Localization | Cytoplasm . Nucleus . Shuttles be cytoplasm and the nucleus in a XPO1/CRM1-dependent manner. | |
| Protein Description | Negative regulator of the non-canonical NF-kappa-B pathway that acts by mediating deubiquitination of TRAF3, an inhibitor of the NF-kappa-B pathway, thereby acting as a negative regulator of B-cell responses. In response to non-canonical NF-kappa-B stimuli, deubiquitinates 'Lys-48'-linked polyubiquitin chains of TRAF3, preventing TRAF3 proteolysis and over-activation of non-canonical NF-kappa-B. Negatively regulates mucosal immunity against infections (By similarity). Deubiquitinates ZAP70, and thereby regulates T cell receptor (TCR) signaling that leads to the activation of NF-kappa-B. [PubMed: 26903241 Plays a role in T cell homeostasis and is required for normal T cell responses, including production of IFNG and IL2 (By similarity Mediates deubiquitination of EGFR] | |
| Protein Sequence | MTLDMDAVLSDFVRSTGAEPGLARDLLEGKNWDVNAALSDFEQLRQVHAGNLPPSFSEGSGGSRTPEKGFSDREPTRPPRPILQRQDDIVQEKRLSRGISHASSSIVSLARSHVSSNGGGGGSNEHPLEMPICAFQLPDLTVYNEDFRSFIERDLIEQSMLVALEQAGRLNWWVSVDPTSQRLLPLATTGDGNCLLHAASLGMWGFHDRDLMLRKALYALMEKGVEKEALKRRWRWQQTQQNKESGLVYTEDEWQKEWNELIKLASSEPRMHLGTNGANCGGVESSEEPVYESLEEFHVFVLAHVLRRPIVVVADTMLRDSGGEAFAPIPFGGIYLPLEVPASQCHRSPLVLAYDQAHFSALVSMEQKENTKEQAVIPLTDSEYKLLPLHFAVDPGKGWEWGKDDSDNVRLASVILSLEVKLHLLHSYMNVKWIPLSSDAQAPLAQPESPTASAGDEPRSTPESGDSDKESVGSSSTSNEGGRRKEKSKRDREKDKKRADSVANKLGSFGKTLGSKLKKNMGGLMHSKGSKPGGVGTGLGGSSGTETLEKKKKNSLKSWKGGKEEAAGDGPVSEKPPAESVGNGGSKYSQEVMQSLSILRTAMQGEGKFIFVGTLKMGHRHQYQEEMIQRYLSDAEERFLAEQKQKEAERKIMNGGIGGGPPPAKKPEPDAREEQPTGPPAESRAMAFSTGYPGDFTIPRPSGGGVHCQEPRRQLAGGPCVGGLPPYATFPRQCPPGRPYPHQDSIPSLEPGSHSKDGLHRGALLPPPYRVADSYSNGYREPPEPDGWAGGLRGLPPTQTKCKQPNCSFYGHPETNNFCSCCYREELRRREREPDGELLVHRF | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MTLDMDAVL ------CCCCHHHHH | 31.31 | 26714015 | |
| 10 | Phosphorylation | LDMDAVLSDFVRSTG CCHHHHHHHHHHHHC | 23.54 | 26714015 | |
| 30 | Ubiquitination | ARDLLEGKNWDVNAA HHHHHCCCCCCHHHH | 45.55 | 29967540 | |
| 55 | Phosphorylation | HAGNLPPSFSEGSGG HCCCCCCCCCCCCCC | 39.19 | 30576142 | |
| 57 | Phosphorylation | GNLPPSFSEGSGGSR CCCCCCCCCCCCCCC | 45.44 | 29396449 | |
| 60 | Phosphorylation | PPSFSEGSGGSRTPE CCCCCCCCCCCCCCC | 35.61 | 29116813 | |
| 63 | Phosphorylation | FSEGSGGSRTPEKGF CCCCCCCCCCCCCCC | 36.18 | 25159151 | |
| 65 | Phosphorylation | EGSGGSRTPEKGFSD CCCCCCCCCCCCCCC | 37.18 | 25159151 | |
| 76 | Phosphorylation | GFSDREPTRPPRPIL CCCCCCCCCCCCCCC | 51.56 | 29496963 | |
| 93 | Ubiquitination | QDDIVQEKRLSRGIS CCHHHHHHHHHHHHC | 41.36 | 21906983 | |
| 94 | Ubiquitination | DDIVQEKRLSRGISH CHHHHHHHHHHHHCH | 36.82 | 22817900 | |
| 98 | Ubiquitination | QEKRLSRGISHASSS HHHHHHHHHCHHHHH | 23.52 | 22817900 | |
| 100 | Phosphorylation | KRLSRGISHASSSIV HHHHHHHCHHHHHHH | 18.80 | 29255136 | |
| 103 | Phosphorylation | SRGISHASSSIVSLA HHHHCHHHHHHHHHH | 21.13 | 21712546 | |
| 104 | Phosphorylation | RGISHASSSIVSLAR HHHCHHHHHHHHHHH | 25.52 | 23911959 | |
| 105 | Phosphorylation | GISHASSSIVSLARS HHCHHHHHHHHHHHH | 25.23 | 26055452 | |
| 108 | Phosphorylation | HASSSIVSLARSHVS HHHHHHHHHHHHHCC | 18.03 | 23403867 | |
| 115 | Phosphorylation | SLARSHVSSNGGGGG HHHHHHCCCCCCCCC | 16.80 | 22798277 | |
| 134 | Ubiquitination | PLEMPICAFQLPDLT CCCCCEEEEECCCCE | 8.92 | 21890473 | |
| 144 | Ubiquitination | LPDLTVYNEDFRSFI CCCCEEECHHHHHHH | 37.72 | 22817900 | |
| 148 | Ubiquitination | TVYNEDFRSFIERDL EEECHHHHHHHHHHH | 42.87 | 22817900 | |
| 149 | Phosphorylation | VYNEDFRSFIERDLI EECHHHHHHHHHHHH | 30.48 | - | |
| 159 | Phosphorylation | ERDLIEQSMLVALEQ HHHHHHHHHHHHHHH | 10.99 | - | |
| 184 | Ubiquitination | DPTSQRLLPLATTGD CCCCCCEECEEECCC | 3.39 | 21890473 | |
| 218 | Phosphorylation | LMLRKALYALMEKGV HHHHHHHHHHHHHCC | 11.53 | - | |
| 223 | Ubiquitination | ALYALMEKGVEKEAL HHHHHHHHCCCHHHH | 55.05 | 21906983 | |
| 227 | Ubiquitination | LMEKGVEKEALKRRW HHHHCCCHHHHHHHH | 45.97 | 22817900 | |
| 243 | Ubiquitination | WQQTQQNKESGLVYT HHHHHHHHHCCCEEC | 49.25 | - | |
| 256 | Ubiquitination | YTEDEWQKEWNELIK ECHHHHHHHHHHHHH | 66.81 | 29967540 | |
| 263 | Ubiquitination | KEWNELIKLASSEPR HHHHHHHHHHHCCCC | 51.10 | 21890473 | |
| 263 | Ubiquitination | KEWNELIKLASSEPR HHHHHHHHHHHCCCC | 51.10 | 21890473 | |
| 371 | Phosphorylation | SMEQKENTKEQAVIP CHHHHCCCCCCEEEE | 36.73 | - | |
| 372 | Ubiquitination | MEQKENTKEQAVIPL HHHHCCCCCCEEEEC | 60.45 | 32015554 | |
| 376 | Ubiquitination | ENTKEQAVIPLTDSE CCCCCCEEEECCCCC | 4.65 | 23000965 | |
| 382 | Ubiquitination | AVIPLTDSEYKLLPL EEEECCCCCEEEEEE | 37.28 | 23000965 | |
| 385 | Ubiquitination | PLTDSEYKLLPLHFA ECCCCCEEEEEEEEE | 39.22 | 29967540 | |
| 387 | Ubiquitination | TDSEYKLLPLHFAVD CCCCEEEEEEEEEEC | 3.57 | 23000965 | |
| 397 | Ubiquitination | HFAVDPGKGWEWGKD EEEECCCCCCCCCCC | 67.26 | 29967540 | |
| 426 | Ubiquitination | EVKLHLLHSYMNVKW HHHHHHHHHHCCCEE | 24.20 | 23000965 | |
| 432 | Ubiquitination | LHSYMNVKWIPLSSD HHHHCCCEEEECCCC | 34.11 | 23000965 | |
| 435 | Ubiquitination | YMNVKWIPLSSDAQA HCCCEEEECCCCCCC | 25.69 | 23000965 | |
| 437 | Phosphorylation | NVKWIPLSSDAQAPL CCEEEECCCCCCCCC | 22.33 | 30266825 | |
| 437 | Ubiquitination | NVKWIPLSSDAQAPL CCEEEECCCCCCCCC | 22.33 | 23000965 | |
| 438 | Phosphorylation | VKWIPLSSDAQAPLA CEEEECCCCCCCCCC | 44.65 | 30266825 | |
| 441 | Ubiquitination | IPLSSDAQAPLAQPE EECCCCCCCCCCCCC | 48.80 | 23000965 | |
| 446 | Ubiquitination | DAQAPLAQPESPTAS CCCCCCCCCCCCCCC | 50.40 | 23000965 | |
| 449 | Phosphorylation | APLAQPESPTASAGD CCCCCCCCCCCCCCC | 33.94 | 30266825 | |
| 451 | Phosphorylation | LAQPESPTASAGDEP CCCCCCCCCCCCCCC | 42.39 | 30266825 | |
| 453 | Phosphorylation | QPESPTASAGDEPRS CCCCCCCCCCCCCCC | 34.95 | 30266825 | |
| 460 | Phosphorylation | SAGDEPRSTPESGDS CCCCCCCCCCCCCCC | 60.06 | 23927012 | |
| 461 | Phosphorylation | AGDEPRSTPESGDSD CCCCCCCCCCCCCCC | 32.15 | 23927012 | |
| 464 | Phosphorylation | EPRSTPESGDSDKES CCCCCCCCCCCCHHC | 49.45 | 23927012 | |
| 467 | Phosphorylation | STPESGDSDKESVGS CCCCCCCCCHHCCCC | 54.85 | 23927012 | |
| 471 | O-linked_Glycosylation | SGDSDKESVGSSSTS CCCCCHHCCCCCCCC | 37.20 | 23301498 | |
| 471 | Phosphorylation | SGDSDKESVGSSSTS CCCCCHHCCCCCCCC | 37.20 | 23927012 | |
| 474 | Phosphorylation | SDKESVGSSSTSNEG CCHHCCCCCCCCCCC | 20.96 | 23927012 | |
| 475 | Phosphorylation | DKESVGSSSTSNEGG CHHCCCCCCCCCCCC | 31.54 | 23927012 | |
| 476 | Phosphorylation | KESVGSSSTSNEGGR HHCCCCCCCCCCCCC | 37.24 | 23927012 | |
| 477 | Phosphorylation | ESVGSSSTSNEGGRR HCCCCCCCCCCCCCC | 37.20 | 23403867 | |
| 478 | Phosphorylation | SVGSSSTSNEGGRRK CCCCCCCCCCCCCCC | 34.53 | 23403867 | |
| 501 | Phosphorylation | KDKKRADSVANKLGS HHHHHHHHHHHHHHH | 23.34 | 23403867 | |
| 505 | Acetylation | RADSVANKLGSFGKT HHHHHHHHHHHHHHH | 44.48 | 25953088 | |
| 505 | Ubiquitination | RADSVANKLGSFGKT HHHHHHHHHHHHHHH | 44.48 | 23000965 | |
| 508 | Phosphorylation | SVANKLGSFGKTLGS HHHHHHHHHHHHHHH | 41.06 | 25849741 | |
| 511 | Ubiquitination | NKLGSFGKTLGSKLK HHHHHHHHHHHHHHH | 38.27 | 23000965 | |
| 512 | Phosphorylation | KLGSFGKTLGSKLKK HHHHHHHHHHHHHHH | 36.41 | 26434776 | |
| 514 | Ubiquitination | GSFGKTLGSKLKKNM HHHHHHHHHHHHHHC | 28.15 | 23000965 | |
| 515 | Ubiquitination | SFGKTLGSKLKKNMG HHHHHHHHHHHHHCC | 37.62 | 22817900 | |
| 516 | Ubiquitination | FGKTLGSKLKKNMGG HHHHHHHHHHHHCCC | 63.63 | 23000965 | |
| 517 | Ubiquitination | GKTLGSKLKKNMGGL HHHHHHHHHHHCCCC | 11.63 | 22817900 | |
| 520 | Ubiquitination | LGSKLKKNMGGLMHS HHHHHHHHCCCCCCC | 32.51 | 23000965 | |
| 522 | Ubiquitination | SKLKKNMGGLMHSKG HHHHHHCCCCCCCCC | 35.16 | 22817900 | |
| 525 | Ubiquitination | KKNMGGLMHSKGSKP HHHCCCCCCCCCCCC | 3.66 | 23000965 | |
| 527 | Phosphorylation | NMGGLMHSKGSKPGG HCCCCCCCCCCCCCC | 25.42 | 29449344 | |
| 530 | Phosphorylation | GLMHSKGSKPGGVGT CCCCCCCCCCCCCCC | 39.14 | 30175587 | |
| 531 | Ubiquitination | LMHSKGSKPGGVGTG CCCCCCCCCCCCCCC | 57.24 | 29967540 | |
| 536 | Ubiquitination | GSKPGGVGTGLGGSS CCCCCCCCCCCCCCC | 19.83 | 22817900 | |
| 537 | Phosphorylation | SKPGGVGTGLGGSSG CCCCCCCCCCCCCCC | 27.16 | 27732954 | |
| 537 | Ubiquitination | SKPGGVGTGLGGSSG CCCCCCCCCCCCCCC | 27.16 | 22817900 | |
| 542 | Phosphorylation | VGTGLGGSSGTETLE CCCCCCCCCCCHHHH | 24.64 | 29255136 | |
| 543 | Phosphorylation | GTGLGGSSGTETLEK CCCCCCCCCCHHHHH | 53.67 | 29255136 | |
| 545 | Phosphorylation | GLGGSSGTETLEKKK CCCCCCCCHHHHHHH | 27.95 | 29255136 | |
| 547 | Phosphorylation | GGSSGTETLEKKKKN CCCCCCHHHHHHHHC | 39.80 | 29255136 | |
| 555 | Phosphorylation | LEKKKKNSLKSWKGG HHHHHHCCCCCCCCC | 46.16 | 24719451 | |
| 565 | Ubiquitination | SWKGGKEEAAGDGPV CCCCCCCCCCCCCCC | 47.51 | 22817900 | |
| 567 | Ubiquitination | KGGKEEAAGDGPVSE CCCCCCCCCCCCCCC | 21.64 | 22817900 | |
| 572 | Ubiquitination | EAAGDGPVSEKPPAE CCCCCCCCCCCCCHH | 16.45 | 22817900 | |
| 574 | Ubiquitination | AGDGPVSEKPPAESV CCCCCCCCCCCHHHC | 70.58 | 22817900 | |
| 576 | Ubiquitination | DGPVSEKPPAESVGN CCCCCCCCCHHHCCC | 29.31 | 22817900 | |
| 581 | Ubiquitination | EKPPAESVGNGGSKY CCCCHHHCCCCCCHH | 5.34 | 22817900 | |
| 586 | Ubiquitination | ESVGNGGSKYSQEVM HHCCCCCCHHHHHHH | 29.80 | 22817900 | |
| 587 | Ubiquitination | SVGNGGSKYSQEVMQ HCCCCCCHHHHHHHH | 52.80 | 22817900 | |
| 589 | Phosphorylation | GNGGSKYSQEVMQSL CCCCCHHHHHHHHHH | 24.49 | 22210691 | |
| 595 | Phosphorylation | YSQEVMQSLSILRTA HHHHHHHHHHHHHHH | 13.14 | 22210691 | |
| 595 | Ubiquitination | YSQEVMQSLSILRTA HHHHHHHHHHHHHHH | 13.14 | 22817900 | |
| 596 | Ubiquitination | SQEVMQSLSILRTAM HHHHHHHHHHHHHHH | 1.76 | 22817900 | |
| 631 | Phosphorylation | QEEMIQRYLSDAEER HHHHHHHHHHHHHHH | 8.32 | 29449344 | |
| 633 | Phosphorylation | EMIQRYLSDAEERFL HHHHHHHHHHHHHHH | 26.32 | 28857561 | |
| 644 | Ubiquitination | ERFLAEQKQKEAERK HHHHHHHHHHHHHHH | 55.64 | 21906983 | |
| 646 | Ubiquitination | FLAEQKQKEAERKIM HHHHHHHHHHHHHHH | 66.96 | 22817900 | |
| 651 | Ubiquitination | KQKEAERKIMNGGIG HHHHHHHHHHCCCCC | 37.50 | 22817900 | |
| 653 | Ubiquitination | KEAERKIMNGGIGGG HHHHHHHHCCCCCCC | 4.23 | 22817900 | |
| 655 | Ubiquitination | AERKIMNGGIGGGPP HHHHHHCCCCCCCCC | 16.24 | 22817900 | |
| 660 | Ubiquitination | MNGGIGGGPPPAKKP HCCCCCCCCCCCCCC | 26.74 | 22817900 | |
| 665 | Ubiquitination | GGGPPPAKKPEPDAR CCCCCCCCCCCCCCC | 74.71 | 22817900 | |
| 666 | Ubiquitination | GGPPPAKKPEPDARE CCCCCCCCCCCCCCC | 57.63 | 21906983 | |
| 674 | Ubiquitination | PEPDAREEQPTGPPA CCCCCCCCCCCCCCH | 57.20 | 22817900 | |
| 675 | Ubiquitination | EPDAREEQPTGPPAE CCCCCCCCCCCCCHH | 35.78 | 22817900 | |
| 677 | Phosphorylation | DAREEQPTGPPAESR CCCCCCCCCCCHHHH | 63.11 | 23090842 | |
| 683 | Phosphorylation | PTGPPAESRAMAFST CCCCCHHHHHCCCCC | 27.69 | 23090842 | |
| 700 | Methylation | PGDFTIPRPSGGGVH CCCCCCCCCCCCCCC | 33.88 | - | |
| 702 | Phosphorylation | DFTIPRPSGGGVHCQ CCCCCCCCCCCCCCC | 51.88 | 28555341 | |
| 727 | Phosphorylation | CVGGLPPYATFPRQC CCCCCCCCCCCCCCC | 19.14 | 27642862 | |
| 729 | Phosphorylation | GGLPPYATFPRQCPP CCCCCCCCCCCCCCC | 28.47 | 28348404 | |
| 740 | Phosphorylation | QCPPGRPYPHQDSIP CCCCCCCCCCCCCCC | 16.40 | 27080861 | |
| 745 | Phosphorylation | RPYPHQDSIPSLEPG CCCCCCCCCCCCCCC | 29.81 | 23312004 | |
| 748 | Phosphorylation | PHQDSIPSLEPGSHS CCCCCCCCCCCCCCC | 43.63 | 23312004 | |
| 753 | Phosphorylation | IPSLEPGSHSKDGLH CCCCCCCCCCCCCCC | 34.99 | 28555341 | |
| 769 | Phosphorylation | GALLPPPYRVADSYS CCCCCCCCEECCCCC | 24.40 | 28674419 | |
| 775 | Phosphorylation | PYRVADSYSNGYREP CCEECCCCCCCCCCC | 13.50 | 27642862 | |
| 779 | Phosphorylation | ADSYSNGYREPPEPD CCCCCCCCCCCCCCC | 18.96 | 22817900 | |
| 808 | Phosphorylation | KCKQPNCSFYGHPET CCCCCCCCCCCCCCC | 28.30 | 22210691 | |
| 810 | Phosphorylation | KQPNCSFYGHPETNN CCCCCCCCCCCCCCC | 9.76 | 22210691 | |
| 823 | Phosphorylation | NNFCSCCYREELRRR CCCCHHHHHHHHHHH | 25.95 | 22210691 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of OTU7B_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of OTU7B_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of OTU7B_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| NHRF2_HUMAN | SLC9A3R2 | physical | 19615732 | |
| NU155_HUMAN | NUP155 | physical | 19615732 | |
| ACAD9_HUMAN | ACAD9 | physical | 19615732 | |
| HIF1N_HUMAN | HIF1AN | physical | 19615732 | |
| PARK7_HUMAN | PARK7 | physical | 21097510 | |
| EGFR_HUMAN | EGFR | physical | 22179831 | |
| UBC_HUMAN | UBC | physical | 20622874 | |
| UBE2S_HUMAN | UBE2S | physical | 20622874 | |
| XPO1_HUMAN | XPO1 | physical | 21888622 | |
| UBC_HUMAN | UBC | physical | 23827681 | |
| P55G_HUMAN | PIK3R3 | physical | 25814554 | |
| UBC_HUMAN | UBC | physical | 25752577 | |
| UBC_HUMAN | UBC | physical | 25723849 | |
| AURKA_HUMAN | AURKA | physical | 26446837 | |
| UBC_HUMAN | UBC | physical | 26876099 | |
| UBC_HUMAN | UBC | physical | 27732584 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-100, AND MASSSPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-464 AND SER-467, ANDMASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-100, AND MASSSPECTROMETRY. | |
| "Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-100, AND MASSSPECTROMETRY. | |
| "Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-449, AND MASSSPECTROMETRY. | |